Skip to main content
Home

Language & Country Selector for Desktop

language-selector-globe India | en

Choose Location

  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
  • Argentina | es
  • Brazil | pt
  • Canada | fr
  • Canada | en
  • Central America | es
  • Colombia | es
  • Mexico | es
  • United States | en
  • Venezuela | es
  • Australia | en
  • Bangladesh | en
  • Hong Kong S.A.R. | zh
  • India | en
  • Indonesia | en
  • Japan | ja
  • Korea | ko
  • Mainland China | zh
  • Malaysia | en
  • Pakistan | en
  • Philippines | en
  • Singapore | en
  • Taiwan | zh
  • Austria | de
  • Belgium | nl
  • Belgium | fr
  • Bulgaria | bg
  • Czech Republic | en
  • Czech Republic | cs
  • Denmark | da
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hungary | hu
  • Ireland | en
  • Italy | it
  • Latvia | lv
  • Lithuania | lt
  • Netherlands | nl
  • Norway | no
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Slovakia | sk
  • Spain | es
  • Sweden | sv
  • Switzerland | fr
  • Switzerland | de
  • United Kingdom | en
  • Global | en
  • Novartis Foundation | en
  • Sandoz | en
  • Egypt | en
  • Israel | he
  • South Africa | en
  • Turkey | tr

Language & Country Selector for Mobile

language-selector-globe India

Choose Location

Americas Asia Pacific Europe International Middle East & Africa
  • Argentina | es
  • Australia | en
  • Austria | de
  • Bangladesh | en
  • Belgium | nl
  • Belgium | fr
  • Brazil | pt
  • Bulgaria | bg
  • Canada | fr
  • Canada | en
  • Central America | es
  • Colombia | es
  • Czech Republic | en
  • Czech Republic | cs
  • Denmark | da
  • Egypt | en
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Global | en
  • Greece | el
  • Hong Kong S.A.R. | zh
  • Hungary | hu
  • India | en
  • Indonesia | en
  • Ireland | en
  • Israel | he
  • Italy | it
  • Japan | ja
  • Korea | ko
  • Latvia | lv
  • Lithuania | lt
  • Mainland China | zh
  • Malaysia | en
  • Mexico | es
  • Netherlands | nl
  • Norway | no
  • Novartis Foundation | en
  • Pakistan | en
  • Philippines | en
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Sandoz | en
  • Serbia | sr
  • Singapore | en
  • Slovakia | sk
  • South Africa | en
  • Spain | es
  • Sweden | sv
  • Switzerland | fr
  • Switzerland | de
  • Taiwan | zh
  • Turkey | tr
  • United Kingdom | en
  • United States | en
  • Venezuela | es
    • About 
      • Novartis in India 
      • Global Drug Development 
      • Strategy 
      • Diversity and Inclusion 
      • People and Culture 
      • Arogya Parivar 
      • India Site Locations 
      • India Country Leadership Team 
      • NIL Board of Directors 
        • Mr. Christopher Snook 
        • Mr. Sanjay Murdeshwar 
        • Mr. Jai Hiremath 
        • Ms. Sandra Martyres 
        • Ms. Monaz Noble 
        • Mr. Sanker Parameswaran 
      • Contact 
      Indian scientist in a lab About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      A couple holding hands Patients and Caregivers
    • Healthcare Professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Scientist in a lab Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      hcp-and-patient ESG
    • Investors 
      • Annual General Meeting 
      • Corporate Policies 
      • Financial Results 
      • Stock Exchange Disclosures 
      • Transfer of Shares to IEPF Demat Account 
      • Novartis India Investors Contact 
      • Novartis India Annual General Meeting 
      • Novartis India Board of Directors 
      nkc-hyderabad Novartis India Investors
    • News 
      • News Archive 
      • Contacts 
      office-meeting News
    • Careers 
      • Career Search 
      • BioCamp 
      • Meet the teams 
      • Personal Growth 
      • Early Talent 
      • Well-being 
      • Diversity and Inclusion 
      • Awards and Recognition 
      Careers.jpg Careers
    • Coronavirus 
      coronavirus covid 19 page hero image Coronavirus
    hcp-and-patient Home
Header
hcp-and-patient

Environment, Society and Governance

Previous Next
As a global company, Novartis has a great responsibility and an even greater opportunity to lead the world in creating a positive social change, embracing societal impact as a core business objective.
HCP sitting with a patient

Access to medicines

We believe access to medicines is where we can have the greatest impact. For all our new medicines, we systematically integrate access strategies to reach underserved patients no matter where they live.

Mother waiting with an infant in a clinic

Global Health

We apply our expertise and full organizational capability to address major, unresolved global health challenges.

Photo of people walking

Ethics, Risk and Compliance

We recognize society’s expectations of our industry and of Novartis, and that we must go beyond just doing what is legal in order to meet legitimate expectations of society.

Trees in a forest

Environmental Sustainability

We understand the link between the health of our planet and the health of our patients. Our ambition is to be a catalyst for positive change and a leader in environmental sustainability.

Woman smiling and talking with a colleague

Ethical Behavior

At Novartis, we hold ourselves to high ethical standards and do not tolerate unethical behavior.

Business people meeting in a room

Materiality Assessment and Reporting

Our ESG priorities are defined by our materiality assessment, it helps us understand what matters to our stakeholders and how they perceive our impact

Novartis India

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
  • Contacts
Media Center
  • News Archive
Our Portfolio
  • Novartis Clinical Pipeline
Other Novartis websites
  • Global site
  • Novartis MedHub India
Footer Bottom
© 2023 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Web Accessibility
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for an audience in India